Common Contracts
2 similar Exclusive Option Agreement contracts by Via Pharmaceuticals, Inc.
EX-10.8 10 dex108.htm EXCLUSIVE OPTION AGREEMENT EXCLUSIVE OPTION AGREEMENTExclusive Option Agreement • May 5th, 2020
THIS AGREEMENT is made and entered into as of 27 day of March (the “Effective Date”) by and between SANTEN PHARMACEUTICAL CO., LTD. (“SANTEN”), a Japanese corporation having a place of business at 9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533-8651, Japan, and VIA PHARMACEUTICALS, INC. (“VIA”), a Delaware corporation having a place of business at 750 Battery Street, Suite 330, San Francisco, CA 94111, USA.
EXCLUSIVE OPTION AGREEMENTExclusive Option Agreement • August 14th, 2007 • Via Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
THIS AGREEMENT is made and entered into as of 27 day of March (the “Effective Date”) by and between SANTEN PHARMACEUTICAL CO., LTD. (“SANTEN”), a Japanese corporation having a place of business at 9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533-8651, Japan, and VIA PHARMACEUTICALS, INC. (“VIA”), a Delaware corporation having a place of business at 750 Battery Street, Suite 330, San Francisco, CA 94111, USA.
